RAPT - Total Utang marang Modal rapt.com

Logo perusahaan publik RAPT Therapeutics (RAPT)

The daily price chart for RAPT Therapeutics, Inc. (RAPT) reflects the 0.02 metric, driven by expectations surrounding dermatitis therapy and the potential for acquisition by industry behemoths. Meanwhile, market caution stems from a strategic development pivot following research pauses. The business relies on AI platforms that automate the creation of anti-tumor compounds, eliminating routine tasks for researchers.

RAPT: Total Utang marang Modal RAPT Therapeutics 04.07.2022 - 14.03.2026

Rincian analitis perusahaan RAPT Therapeutics, Inc.

- rega lan prakiraan konsensus rega:
Bagan rega RAPT Therapeutics, Inc.|RAPT - Bagan tingkat prakiraan
- statistik kapitalisasi pasar:
Kapitalisasi pasar RAPT Therapeutics|RAPT - Nilai Dipunlarasaken Utang lan Kas
- indikator kapitalisasi buku:
Nilai Buku saben Saham RAPT Therapeutics|RAPT - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku rapt.com|RAPT - Nilai Agregat Aset
- indikator total utang lan likuiditas perusahaan:
Utang marang Ekuitas RAPT Therapeutics, Inc.|RAPT - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal RAPT Therapeutics|RAPT - Gunggung utang perusahaan|Utang marang nilai buku RAPT Therapeutics|RAPT - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan RAPT Therapeutics|Likuiditas cepet rapt.com
- informasi bathi lan kelipatan valuasi:
RAPT - Penghasilan resik
Analisis dhasar perusahaan:RAPT Therapeutics, Inc.
Barang utama rapt.com

RAPT Therapeutics, Inc. (RAPT) automates immuno-oncology design through robotic bio-screening and AI. The current leverage ratio (total debt to equity) reflects the proportion of borrowed funds relative to the company's own assets. This metric measures financial stability and the extent of the business's dependence on creditors. Analysis of this chart allows for an assessment of the balance between aggressive technological development and debt load. A low ratio confirms the funding autonomy of capital-intensive digital developments.

Analisis pesaing RAPT Therapeutics, Inc.

Utang marang Ekuitas argenx|BioNTech Inc. - Utang Agregat marang Ekuitas|Total Utang marang Modal ABVX|ADMA (ADMA Corp) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal PTGX (Protagonist Therapeutics)|Total Utang marang Modal immunovant.com IMVT|KNSA - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi GRFS (Grifols SA)|Adaptive Biotechnologies Corp (ADPT) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Celldex Corp|AUPH (Aurinia Pharmaceuticals) - Total Utang marang Modal|Total Utang marang Modal biocryst.com|Rasio Total Utang marang Ekuitas VERA (Vera Therapeutics)|DNTH (Dianthus Therapeutics Inc) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal PHVS (Pharvaris Corp)|Koefisien Total Utang marang Modal AbCellera (ABCL)|TRML - Utang marang Ekuitas|precigen.com (PGEN) - Rasio Total Utang marang Ekuitas|Pharming Group (PHAR) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Nektar Therapeutics Inc|Rasio Total Utang marang Ekuitas UPB|Total Utang marang Modal Zenas Corp|Utang marang Ekuitas Immunome, Inc. (IMNM)|gossamerbio.com - Rasio Utang marang Ekuitas|Total Utang marang Modal KALV (KalVista Pharmaceuticals, Inc.)|Septerna, Inc. (SEPN) - Utang marang Modal|PVLA - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi SVRA (Savara Pharma)|RIGL: Total Utang marang Modal|anaptysbio.com (ANAB) - Total Utang marang Modal|Utang marang Ekuitas Astria Therapeutics, Inc.|enGene Holdings Inc - Utang Agregat marang Ekuitas|Rasio Total Utang marang Ekuitas JBIO (Aerovate Therapeutics Inc)|Utang Agregat marang Modal ACRS|Kyverna Therapeutics - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi TLSA|CABA: Rasio Total Utang marang Ekuitas|Ventyx Biosciences Inc. - Utang Agregat marang Modal|THTX: Total Utang marang Modal|Avalo Therapeutics Inc - Rasio Kabeh Utang marang Dana Pribadi|ELDN (Eledon Pharmaceuticals) - Total Utang marang Modal|Utang marang Modal agenusbio.com AGEN|Utang marang Ekuitas Climb Bio (CLYM)|ZURA (Zura Bio Ltd) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal ATYR (aTyr)|Total Utang marang Modal Adagene Inc ADAG|IMA - Utang marang Ekuitas|Utang Agregat marang Ekuitas STTK|EQ: Total Utang marang Modal|Utang marang Modal Connect Biopharma Holdings Limited (CNTB)|Rasio Total Utang marang Ekuitas IMUX|Total Utang marang Modal Atara Biotherapeutics Inc|Rasio Total Utang marang Ekuitas IFRX (InflaRx N.V.)|Utang Agregat marang Modal XFOR|Total Utang marang Modal ACET (Adicet Bio, Inc.)|Koefisien Total Utang marang Modal Celularity Inc (CELU)|INmune Bio Corp - Total Utang marang Modal|Barinthus Biotherapeutics Corp (BRNS) - Rasio Total Utang marang Ekuitas|Kezar Life Sciences (KZR) - Utang marang Ekuitas|SABS - Koefisien Total Utang marang Modal|Rasio Total Utang marang Ekuitas AKTX|ENLV: Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal QTTB|Koefisien Total Utang marang Modal GeoVax Corp|Utang marang Ekuitas Edesa Biotech, Inc. EDSA|IBIO: Rasio Utang marang Ekuitas|Carisma Tx - Total Utang marang Modal|XTL Biopharmaceuticals Ltd (XTLB) - Rasio Total Utang marang Ekuitas|BOLT (boltbio.com) - Rasio Total Utang marang Ekuitas|HCWB - Koefisien Total Utang marang Modal|Utang marang Ekuitas Aptevo Therapeutics, Inc.|AIM: Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal ADTX|Total Utang marang Modal GRI Bio Inc (GRI)|Utang marang Ekuitas XORTX XRTX|HIND (Vyome Therapeutics) - Utang Agregat marang Ekuitas|REVB: Rasio Total Utang marang Ekuitas|indaptusrx.com - Utang Agregat marang Modal|Scinai Immunotherapeutics Ltd. (SCNI) - Utang marang Ekuitas|Utang Agregat marang Ekuitas CALI (CalciMedica)|AFMD (Affimed NV) - Total Utang marang Modal|ALLK: Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal HOOK|Total Utang marang Modal igmbio.com (IGMS)|Utang marang Ekuitas iTeos Therapeutics, Inc. ITOS|Rasio Kabeh Utang marang Dana Pribadi OCEA|TCBP - Utang marang Ekuitas|Third Harmonic Bio Inc (THRD) - Rasio Total Utang marang Ekuitas